tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BCRX Stock Latest News

3 Best Value Stocks with Over 20% Upside in 2026, According to Analysts 
Market News3 Best Value Stocks with Over 20% Upside in 2026, According to Analysts 
8h ago
DOX
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
14d ago
BCRX
BioCryst price target raised to $22 from $21 at Wedbush
PremiumThe Fly
BioCryst price target raised to $22 from $21 at Wedbush
16d ago
BCRX
Brand Risks Emerge in BioCryst’s ORLADEYO Sale to Neopharmed as Fragmented Positioning Threatens Long‑Term Value
PremiumCompany Announcements
Brand Risks Emerge in BioCryst’s ORLADEYO Sale to Neopharmed as Fragmented Positioning Threatens Long‑Term Value
18d ago
BCRX
BioCryst Earnings Call Highlights Profits, Pipeline Momentum
PremiumCompany Announcements
BioCryst Earnings Call Highlights Profits, Pipeline Momentum
18d ago
BCRX
BioCryst Boosts HAE Franchise With Astria Acquisition, Guidance
PremiumCompany AnnouncementsBioCryst Boosts HAE Franchise With Astria Acquisition, Guidance
20d ago
8K
BCRX
BioCryst reports Q4 EPS $1.12 vs (13c) last year
Premium
The Fly
BioCryst reports Q4 EPS $1.12 vs (13c) last year
20d ago
BCRX
BioCryst sees FY26 revenue $635M-$660M, consensus $657.1M
Premium
The Fly
BioCryst sees FY26 revenue $635M-$660M, consensus $657.1M
20d ago
BCRX
Is BCRX a Buy, Before Earnings?
PremiumPre-Earnings
Is BCRX a Buy, Before Earnings?
22d ago
BCRX
BioCryst resumed with an Outperform at Evercore ISI
PremiumThe Fly
BioCryst resumed with an Outperform at Evercore ISI
28d ago
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
1M ago
BCRX
BioCryst Closes Blackstone Loan and Astria Acquisition
PremiumCompany Announcements
BioCryst Closes Blackstone Loan and Astria Acquisition
2M ago
8K
BCRX
BioCryst completes acquisition of Astria Therapeutics
PremiumThe FlyBioCryst completes acquisition of Astria Therapeutics
2M ago
ATXS
BCRX
Astria stockholders vote to approve acquisition by BioCryst
Premium
The Fly
Astria stockholders vote to approve acquisition by BioCryst
2M ago
ATXS
BCRX
BioCryst: Sustained Orladeyo Momentum, Disciplined Financials, and Pipeline Upside Support Buy Rating
Premium
Ratings
BioCryst: Sustained Orladeyo Momentum, Disciplined Financials, and Pipeline Upside Support Buy Rating
2M ago
BCRX
BioCryst Updates ORLADEYO Revenue Outlook and Guidance
PremiumCompany Announcements
BioCryst Updates ORLADEYO Revenue Outlook and Guidance
2M ago
8K
BCRX
BioCryst reports preliminary Q4 ORLADEYO revenue $151M
PremiumThe Fly
BioCryst reports preliminary Q4 ORLADEYO revenue $151M
2M ago
BCRX
BioCryst sees FY26 revenue $635M-$660M
PremiumThe Fly
BioCryst sees FY26 revenue $635M-$660M
2M ago
BCRX
BioCryst Raises Price of Key ORLADEYO Treatment
PremiumCompany Announcements
BioCryst Raises Price of Key ORLADEYO Treatment
2M ago
8K
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe FlyBioCryst reports inducement grants under Nasdaq listing rule
2M ago
BCRX
BioCryst’s Orladeyo Pediatric Approval and Strategic Expansion Drive Buy Rating
Premium
Ratings
BioCryst’s Orladeyo Pediatric Approval and Strategic Expansion Drive Buy Rating
3M ago
BCRX
BioCryst price target raised to $32 from $30 at H.C. Wainwright
Premium
The Fly
BioCryst price target raised to $32 from $30 at H.C. Wainwright
3M ago
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >